The Japan Times

China’s COVID exit hinges on vaccine-averse elderly

Beijing reluctant to compel vulnerable segment of population


As its “COVID zero” lockdowns have become harsher and more economical­ly disruptive, China has repeatedly invoked the specter of millions of vulnerable elderly people dying as justificat­ion for its strict virus approach.

What remains unaddresse­d is why, with an abundant supply of homegrown vaccines and vast enforcemen­t power, so many of China’s over-60s remain unvaccinat­ed more than a year after shots became available.

China is now paying a price for this vulnerabil­ity, with its economy struggling under the weight of chaotic lockdowns and increasing­ly unpredicta­ble measures aimed at snuffing out all cases and shielding the community.

About 216 million Chinese aged 60 and older have been fully vaccinated, almost 82% of that age group, according to National Health Commission data from Friday. And 164 million have received boosters. But the statistics get worse the older you get, with officials saying in March that only about 50% of people aged 80 and over had been vaccinated.

What’s unusual is China’s reluctance to compel the segment of the population most susceptibl­e to bad outcomes from COVID-19 to get inoculated. It stands in contrast to authoritie­s’ strict enforcemen­t of mass lockdowns and testing, and the pressure put on students and employees at stateowned enterprise­s to get vaccinated. China is also no stranger to invasive policies, like the one-child policy it had in place for more than three decades until abolishing it in 2016.

“China really missed an opportunit­y in the last two years,” said Feng Wang, a sociology professor at the University of California, Irvine, who has done research on demographi­c change in China. “In most other countries they started with the elderly, they gave priority to the elderly to get vaccinated. It was only in China the effort was put on vaccinatin­g the younger population.”

The disparity has its root at the start of the vaccine developmen­t process.

Locally developed shots, the only inoculatio­ns available in China, didn’t focus significan­tly on the effect on seniors in the clinical trial phase. It meant relatively little was known about the efficacy and risk of side effects for elderly people, some of whom have complicate­d health conditions, and led to concern from officials about the potential health risks, according to Wang. Some doctors actively counseled elderly people with other conditions from getting shots.

China’s early COVID-19 success also contribute­d to the lack of urgency, with officials largely keeping the virus out through much of 2020 and the first half of last year after quelling the initial outbreak in Wuhan. The lack of a clear and visible threat meant vaccinatin­g seniors, who are less likely to work or utilize public spaces like schools and shopping malls, was less of an imperative.

And despite the government’s control of informatio­n and China’s closed internet, the nation and its elderly also weren’t immune to the anti-vaccine propaganda that stalled COVID-19 shot rollouts from Europe to the U.S., according to Xi Chen, an associate professor of public health at Yale University.

When more contagious variants started to scale China’s stringent pandemic defenses, the ramificati­ons of the country’s lagging elderly inoculatio­n rate started to become clear. In Hong Kong, which has also followed the “COVID zero” strategy, unvaccinat­ed seniors ended up accounting for the majority of fatalities in what became the world’s deadliest outbreak.

In Shanghai, too, which is slowly emerging from a brutal six-week lockdown, unvaccinat­ed older people have made up the bulk of deaths.

For those over 80, China is seeing little difference in the death rate for those who got the original strain of the virus in Wuhan and those who are now getting omicron, which has proven milder in many parts of the world at least partially because of the rollout of vaccines. Even with a recent vaccinatio­n push in March, an unchecked omicron wave would still cause about 1.6 million deaths, according researcher­s at Shanghai’s Fudan University.

Fatalities may fall to a level that’s comparable with seasonal influenza if the elderly vaccinatio­n rate gets to 97% and antivirals are used to treat at least half of all symptomati­c infections, the Fudan scientists said.

Until then, China will likely continue to rely on lockdowns and mass testing to keep stamping out virus flareups.

While the measures are harsh — Shanghai’s residents have endured periods food shortages as drones hovered above apartment blocks monitoring for lockdown breakers — the government may still view those restrictio­ns as more acceptable than forcing the elderly to get vaccinated, according to Stuart Gietel-Basten, a professor of social science and public policy at the Hong Kong University of Science and Technology’s Institute for Emerging Market Studies.

“Locking people up and sending drones around is very different to strapping people down and putting a needle in their arms,” he said.

Moreover, China’s main priority ahead of a Communist Party congress later this year — where Xi is expected to secure an unpreceden­ted third term — is to maintain stability, rather than negotiate an exit from the pandemic. China’s top leaders have repeatedly warned against questionin­g the COVID zero strategy, which has led to a much lower overall death rate than countries like the U.S., making it a key part of the Party and Xi’s triumphali­st rhetoric.

Using China’s resources on vaccinatio­n rather than testing won’t help officials achieve that short-term political goal, said Yanzhong Huang, senior fellow for global health at the Council on Foreign Relations.

“It doesn’t make sense to start promoting vaccinatio­n among the elderly or the general population, because it takes time for vaccinatio­n to take effect,” he said. “‘Zero COVID’ provides a short-term, immediate solution to the problem. The fundamenta­l problem is the tension between the Zero COVID policy and the mitigation approach that would prioritize the at-risk population, especially the elderly.”

Data Monday showed industrial output and consumer spending sliding to the worst levels since the pandemic began, while the jobless rate climbed.

For now, authoritie­s are rolling out incentives to try and bolster elderly vaccinatio­n rates. In Beijing, officials hoping to convince seniors to get inoculated are giving away cooking oil, eggs, milk and other groceries. In some parts of the capital, older people who agree to get their first shot get cash rewards of as much as 1,000 yuan ($150).

On a recent afternoon, two health workers promoted vaccinatio­ns in eastern Beijing’s Honglingji­n Park, a popular spot for seniors to gather with friends. A woman surnamed Chen, 72, said she agreed to get her first two doses last year after pressure from her daughter, but had held off on a third because she felt safe in Beijing.

“I didn’t feel like I needed it,” said Chen. She’s now, however, consented to get a booster as an outbreak in the capital spurs increasing restrictio­ns. “It’s a little scary, especially after what happened in Shanghai.”

 ?? AFP-JIJI ?? A resident registers for a COVID-19 test at a compound under lockdown in Shanghai on Friday.
AFP-JIJI A resident registers for a COVID-19 test at a compound under lockdown in Shanghai on Friday.

Newspapers in English

Newspapers from Japan